Sign in

CIK 0001661181

  • Accelerated filer

Organogenesis Holdings Inc.

Sign in to watch
Ticker
ORGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-575-0775
Business address
85 DAN ROAD, CANTON, MA, 02021
Former names
Avista Healthcare Public Acquisition Corp.
  1. 4 Grant or award Director acquired 65,737 shares (grant or award)
  2. 4 Grant or award Director acquired 65,737 shares (grant or award)
  3. 4 Grant or award Director acquired 65,737 shares (grant or award)
  4. 4 Grant or award Director acquired 65,737 shares (grant or award)
  5. 4 Shares withheld for taxes VP Health Policy & Contracting gave up 1,966 shares (to pay taxes)
  6. 4 Shares withheld for taxes VP and General Counsel gave up 4,400 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Commercial Officer gave up 4,145 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Operating Officer gave up 5,535 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 4,459 shares (to pay taxes)
  10. 4 Shares withheld for taxes President and CEO gave up 25,304 shares (to pay taxes)
  11. 4 Open-market buy 10% owner bought 6,000 shares at an average $2.57 ($15,390)
  12. 4 Option exercise Chief Commercial Officer acquired 805 shares (option exercise)
  13. 4 Open-market buy Director bought 3,000 shares at $4.76 ($14,265)
  14. 4 Open-market buy Director bought 5,000 shares at $4.80 ($24,000)
  15. 4 Option exercise President and CEO acquired 505,050 shares (option exercise)
  16. 4 Open-market sale 10% owner sold 30,000 shares at an average $4.89 ($146,836)
  17. 4 Open-market sale 10% owner sold 30,000 shares at an average $4.89 ($146,836)
  18. 4 Open-market sale 10% owner sold 170,000 shares at an average $5.43 ($923,300)
  19. 4 Open-market sale 10% owner sold 170,000 shares at an average $5.43 ($923,300)
  20. 4 Open-market sale President and CEO sold 247,334 shares at an average $5.55 ($1,372,643)

Page 7 of 17 · 321 filings